These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38978237)

  • 1. Vitamin D and Lipid Profiles in Infertile PCOS and Non-PCOS Females.
    Azhar A; Alam SM; Rehman R
    J Coll Physicians Surg Pak; 2024 Jul; 34(7):767-770. PubMed ID: 38978237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
    Wang L; Lv S; Li F; Yu X; Bai E; Yang X
    Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
    [No Abstract]   [Full Text] [Related]  

  • 3. Triglycerides as a Metabolic Target in Afrocaribbean Infertile Women with Polycystic Ovary Syndrome.
    Brouzeng C; Bachelot A; Moriniere C; Vaillant J; Joguet G; Velayoudom FL
    Metab Syndr Relat Disord; 2019 Dec; 17(10):500-504. PubMed ID: 31592705
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome.
    Li HW; Brereton RE; Anderson RA; Wallace AM; Ho CK
    Metabolism; 2011 Oct; 60(10):1475-81. PubMed ID: 21550088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 25-hydroxyvitamin D and metabolic parameters between women with and without polycystic ovarian syndrome.
    Ng BK; Lee CL; Lim PS; Othman H; Ismail NAM
    Horm Mol Biol Clin Investig; 2017 Jun; 31(3):. PubMed ID: 28586302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of vitamin D and evening primrose oil co-supplementation on lipid profiles and biomarkers of oxidative stress in vitamin D-deficient women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
    Nasri K; Akrami S; Rahimi M; Taghizadeh M; Behfar M; Mazandaranian MR; Kheiry A; Memarzadeh MR; Asemi Z
    Endocr Res; 2018 Feb; 43(1):1-10. PubMed ID: 28742409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of lipid profile and obesity in patients with polycystic ovary syndrome.
    Parveen S; Khan S; Khan MM; Gupta B; Ahmad A; Alam R
    Endocr Regul; 2024 Jan; 58(1):83-90. PubMed ID: 38656255
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.
    Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B
    Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D Deficiency among Adolescent Females with Polycystic Ovary Syndrome.
    Sadhir M; Kansra AR; Menon S
    J Pediatr Adolesc Gynecol; 2015 Oct; 28(5):378-81. PubMed ID: 26209866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
    Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
    Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J; Bergh T; Berne C; Lithell H
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.
    Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B
    J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
    Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there any association between vitamin D levels and polycystic ovary syndrome (PCOS) phenotypes?
    Eftekhar M; Mirhashemi ES; Molaei B; Pourmasumi S
    Arch Endocrinol Metab; 2020 Feb; 64(1):11-16. PubMed ID: 31576965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of vitamin D deficiency in infertile women with polycystic ovarian syndrome and its association with metabolic syndrome - A prospective observational study.
    Mogili KD; Karuppusami R; Thomas S; Chandy A; Kamath MS; Tk A
    Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():15-19. PubMed ID: 30096464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid lipoprotein profile alterations in Greek infertile women with polycystic ovaries: influence of adipocytokines levels.
    Tsouma I; Kouskouni E; Demeridou S; Boutsikou M; Hassiakos D; Chasiakou A; Hassiakou S; Gennimata V; Baka S
    In Vivo; 2014; 28(5):935-9. PubMed ID: 25189910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization.
    Dastorani M; Aghadavod E; Mirhosseini N; Foroozanfard F; Zadeh Modarres S; Amiri Siavashani M; Asemi Z
    Reprod Biol Endocrinol; 2018 Oct; 16(1):94. PubMed ID: 30286768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS.
    Roe A; Hillman J; Butts S; Smith M; Rader D; Playford M; Mehta NN; Dokras A
    J Clin Endocrinol Metab; 2014 May; 99(5):E841-7. PubMed ID: 24512495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study on lipoprotein-a and PAI-1 in women with polycystic ovary syndrome.
    Shah AK; Yadav BK; Suri A; Shah AK
    Horm Mol Biol Clin Investig; 2022 Sep; 43(3):357-361. PubMed ID: 35439403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients.
    Karadağ C; Yoldemir T; Yavuz DG
    J Obstet Gynaecol Res; 2018 Feb; 44(2):270-277. PubMed ID: 29094433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.